Cargando…
MicroRNA and diabetic retinopathy—biomarkers and novel therapeutics
Diabetic retinopathy (DR) accounts for ~80% of legal blindness in persons aged 20–74 years and is associated with enormous social and health burdens. Current therapies are invasive, non-curative, and in-effective in 15–25% of DR patients. This review outlines the potential utility of microRNAs (miRN...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421969/ https://www.ncbi.nlm.nih.gov/pubmed/34532417 http://dx.doi.org/10.21037/atm-20-5189 |